Popular topics to explore
5th Sep · SEBI Registration INH000019886
SEBI Registration INH000019886 · 5th Sep
GLOBAL HEALTH LTD – TECHNICAL ANALYSIS With Discussion
MEDANTA Global Health Ltd is currently showing an interesting technical setup on the daily chart. The stock has witnessed a strong upward movement from lower levels and is now consolidating around the ₹1,470 zone. The overall price structu…
26th Aug · SEBI Registration INH000019886
SEBI Registration INH000019886 · 26th Aug
Global Health Ltd. – Bullish Setup Discussion
MEDANTA The stock is currently consolidating near a key support zone, with fresh buying interest emerging after a strong bullish candle. Price action indicates that the support area around ₹1402–₹1438 is holding well, while short-term bull…
Medanta Breaks Major Resistance, Eyes New Highs
MEDANTA Global Health, operating under the Medanta brand, continues to strengthen its fundamental profile through strong patient volumes, capacity expansion and improving contribution from newer hospitals. Q1 FY27 consolidated total income…
PINELABS
══════════════════════════════════════════════ 📊 BULK DEALS | BLOCK DEALS | INSIDER TRADING 📅 Date: 24 June 2026 ══════════════════════════════════════════════ BUYING INTEREST ▶ Credent Global Finance • DP Global Wealth Management boug…
Beds कम, मरीज ज्यादा! Healthcare Sector में बन रहा है Multi-Year Growth Opportunity
भारत में Healthcare Demand लगातार बढ़ रही है, लेकिन Hospital Beds की उपलब्धता अभी भी जरूरत से काफी कम है। कई रिपोर्ट्स के अनुसार देश में लगभग 20 लाख अतिरिक्त Hospital Beds की आवश्यकता है, जबकि Bed-to-Population Ratio अभी भी वैश्विक मानकों स…
Panacea Biotec Soars to Record High on Dengue Vaccine Breakthrough!
Shares of PANACEABIO surged as much as 17% intraday, extending gains for the sixth consecutive session and hitting a fresh all-time high of ₹647. The rally followed the company's announcement of the DENSTAR Project, a major initiative aim…
WOCKPHARMA
Pharmaceutical major Wockhardt jumped more than 10% on Monday after the company received approval from the US Food and Drug Administration (FDA) for its novel antibiotic, Zaynich, marking a significant achievement in its long-standing resea…
Yatharth Hospital & Trauma Care Services Limited – SWOT Analysis
YATHARTH
Strengths
Strong Healthcare Presence in NCR – Well-established multi-specialty hospital network across Noida, Greater Noida, and Delhi-NCR region.
Multi-Specialty Service Portfolio – Presence across cardiology, oncology, neurolo…
Global Longlife Hospital Appoints Mr. Hiren Mandaliya as Additional Independent Director
MEDANTA Global Longlife Hospital and Research Limited has appointed Mr. Hiren Mandaliya (DIN: 11636452) as Additional Director (Non-Executive Independent Director) for a 5-year term effective March 31, 2026. The appointment was approved d…
“Global Health expands capacity—can earnings keep pace with expectations?”
MEDANTA
🏥 New Hospital Expansion
- Noida Facility: 550-bed hospital launched in September 2025.
- Capacity Growth: Mumbai hospital capacity raised from 500 to 750 beds.
- Regional Expansion: Land secured in Guwahati, Assam for a new hos…
Medanta Expands Footprint with ₹550 Cr Strategic Bet on Varanasi Healthcare
MEDANTA, which operates the Medanta chain, is planning a significant expansion by investing around ₹550 crore to establish a ~400-bed super-specialty hospital in Varanasi, targeting a structurally underserved healthcare market in Eastern U…
20th Mar · SEBI Registration INH000015376
SEBI Registration INH000015376 · 20th Mar
High delivery stocks as on 20/03/26
Symbol Delivered Qty
SUNDRMFAST 1076773
GODIGIT 1184356
FIRSTCRY 7414529
AKZOINDIA 98075
ONESOURCE 959273
SAGILITY 64121493
WHIRLPOOL 717331
AUBANK 7708154
IOB 13371036
ESCORTS 382698
GMDCLTD 4300102
MEDANTA 384891
FIRSTCRY
Thomas Cook (India) Limited – Detailed Analysis
THOMASCOOK
Strengths (S)
Strong Brand & Legacy
Well-established brand in India’s travel industry with decades of trust.
Diversified Revenue Streams
Revenue from travel, forex, corporate bookings, and holidays reduces dependency on a sin…
‘Volatility is natural. The real test is…’: Sebi chief’s big message as markets face uncertainty
‘Volatility is natural. The real test is…’: Sebi chief’s big message as markets face uncertainty Securities and Exchange Board of India (Sebi) Chairman Tuhin Kanta Pandey on Saturday said volatility is an inherent feature of financial mark…
9th Mar · SEBI Registration INH000015376
SEBI Registration INH000015376 · 9th Mar
High delivery stocks as on 09/03/26
Symbol & Delivered Qty CERA 19391 DCMSHRIRAM 98582 BPCL 19299354 DEVYANI 1504385 HINDPETRO 11114337 MEDANTA 148566 AUROPHARMA 1214700 AMBER 221254 ASTERDM 906617 PVRINOX 404034 WIPRO 14463173 PNBHOUSING 824165 ULTRACEMCO 357750 AMBUJACEM 23…
22nd Feb · SEBI Registration INH000022729
SEBI Registration INH000022729 · 22nd Feb
Best Pharma & Healthcare Stocks in India! 💊 With strong domestic demand, export growth, and rising healthcare spending, this sector remains structurally strong 📈 🔎 Top Pharma & Healthcare Players: * Dr. Lal PathLabs * Lupin * Kovai Me…
19th Feb · SEBI Registration INH000019886
SEBI Registration INH000019886 · 19th Feb
DATAPATTNS Data Patterns (India) Ltd – Strong Recovery After Sharp Correction (Daily Chart)
After a steep sell-off, the stock has shown a sharp V-shaped recovery and is now trading near a crucial resistance cluster.
🔎 Technical Observat…
17th Feb · SEBI Registration INH000020350
SEBI Registration INH000020350 · 17th Feb
Technical Analysis Global Health Ltd
The stock MEDANTA is currently trading around ₹1,165.70. Looking at the overall structure the stock has transitioned from a period of high volatility into a sideways-to-bullish consolidation phase.
The long-term trend showed a significa…
6th Feb · SEBI Registration INH000019886
SEBI Registration INH000019886 · 6th Feb
Global Health Ltd – Technical View
MEDANTA 📊 Global Health Ltd – Technical View
Timeframe: Daily
After a sharp correction, the stock has bounced from the lower Bollinger Band and is attempting a short-term recovery. Momentum is gradually improving, but price is still near…
Cupid Shares Rally 9%, Extending Two-Day Surge to 26% Amid Q3 Optimism
Shares of CUPID d, India's prominent condom manufacturer, surged 9% in intraday trading on Tuesday, climbing to Rs 433 per share and pushing two-day gains to an impressive 26%. This rebound follows a sharp 36% drop over the previous two se…
